Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMP-114 plus methotrexate in active rheumatoid arthritis
ISRCTN32398235Phase 2Terminated
- Sponsor
- Sumitomo Pharma
- Start
- Feb 2006
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of rimacalib in rheumatoid arthritis (RA) (3 arms), sponsored by Sumitomo Pharma. Primary endpoint: ACR20 at week 24. Started Feb 2006; status: terminated.
02
Drugs
rimacalib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ISRCTN32398235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN32398235.